RK

Ram Kesh Saxena

Active Director Director DIN 06676194
DIN 06676194 First appointment Nov 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2015
Shareholding value •••• Premium profile

About Ram Kesh Saxena

Data last updated:

Ram Kesh Saxena is a Director at Bovicure Pharma Private Limited (since 2015). The company operates in Pharma. Bovicure Pharma Private Limited reported revenue of ₹11.38 Cr (FY 2024).

DIN 06676194
Primary Designation Director
Industry Pharma
First Appointment 19 Nov 2015
Oldest Company Age 13 yrs
Largest company Bovicure Pharma Private Limited · ₹11.38 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bovicure Pharma Private Limited U74900HR2013PTC050746
Director19 Nov 20152013₹11.38 Cr (FY 2024)Active

Board colleagues of Ram Kesh Saxena

NameDINCompanyDesignation
Sushila06676200Bovicure Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Bovicure Pharma Private Limited
Premium access

Shareholding and investment profile for Ram Kesh Saxena

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ram Kesh Saxena

Ram Kesh Saxena currently holds 1 directorship: Bovicure Pharma Private Limited (Director, since 19 Nov 2015, revenue ₹11.38 Cr (FY 2024)).

Ram Kesh Saxena was first appointed on 19 Nov 2015 as Director at Bovicure Pharma Private Limited.

The current boards of Ram Kesh Saxena's companies include Sushila (Bovicure Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available